Clinical Trial

Blended Resources for Integrated Diabetes Guidance and Empowerment

Study acronym: BRIDGE
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 23, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this cluster randomized clinical trial is to learn if an AI-enabled blended care model (the BRIDGE program) works to treat type 2 diabetes in adults. It will also learn about the cost-effectiveness and implementation feasibility of this model in primary care settings. The main questions it aims to answer are: Does the AI-driven intervention lower HbA1c levels (blood sugar) compared to standard care? Does this model improve participants' quality of life, self-management behaviors, and digital literacy? Researchers will compare the "Diet-Medicine Companion" (Shi Yi Ban Lv) mini-program combined with family doctor support to standard community care to see if the blended care model works to manage diabetes. Participants will: Use the "Diet-Medicine Companion" mini-program to upload diet photos daily and receive AI feedback for 6 months Receive periodic guidance and phone reminders from case administrators (family doctors) Complete questionnaires and blood tests (HbA1c) at baseline, 3 months, and 6 months
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-21.
Trial Details
NCT Number NCT07373379
Lead Sponsor Peking University
Conditions Type 2 Diabetes Mellitus
Enrollment 1,200 participants
Start Date 2026-03-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-23